Thoughts from the Frontline

John Mauldin  |

Follow Mauldin as he uncovers the truth behind, and beyond, the financial headlines.Thoughts from the Frontline explores developments overlooked by mainstream news and analyzes challenges and opportunities on the horizon. This in-depth weekly dispatch helps you understand what's happening in the economy and navigate the markets with confidence.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ITKSF Independent Tnkrs Cp Ltd 0.00 0.00 0.00 0

Comments

Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.